; and (ii) if applicable, schedule a pre-approval inspection; and (B) not later than 60 days after receiving such request, conduct a meeting with the applicant to— (i) provide advice to the applicant with respect to the supplemental application; and (ii) if applicable, select a first drug to be identified in accordance with subsection (c). (2) Review and approval In carrying out subsection (a), the Secretary shall— (A) review and take action with respect to a supplemental application not later than 6 months after the date of submission or resubmission of such application; and (B) where the Secretary recommends a change to a domestic establishment following an inspection of such establishment, reinspect the establishment not later than 90 days after receiving a request from the applicant for reinspection. (3) Relation to fee performance goals The deadlines specified in paragraph (1) supersede any conflicting performance goals identified in any statute reauthorizing the fee programs in parts 2 and 7 of subchapter C of title VII of the Federal Food, Drug, and Cosmetic Act. (c) Contents With respect to a supplemental application under subsection (a) for a transfer of the site of manufacture of multiple drugs that share a similar manufacturing process, the Secretary shall— (1) request a list of the drugs; (2) from the list under paragraph (1), identify a first drug to be transferred; (3) determine the criteria necessary to receive approval of the supplemental application